PRELUDE CAPITAL MANAGEMENT, LLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$83,000
+7.8%
8,833
-12.8%
0.00%0.0%
Q2 2020$77,000
+22.2%
10,1270.0%0.00%0.0%
Q1 2020$63,000
+600.0%
10,127
+1029.0%
0.00%
Q2 2019$9,000
-80.9%
897
-71.1%
0.00%
-100.0%
Q4 2018$47,000
+571.4%
3,100
+454.6%
0.00%
+200.0%
Q4 2017$7,000
-84.4%
559
-77.3%
0.00%
-75.0%
Q3 2017$45,000
+542.9%
2,459
+514.8%
0.00%
+300.0%
Q2 2017$7,000
-91.6%
400
-89.1%
0.00%
-87.5%
Q1 2017$83,000
-91.8%
3,664
-87.4%
0.01%
-93.4%
Q4 2016$1,013,000
+95.9%
29,107
+37.9%
0.12%
+125.9%
Q3 2016$517,000
+89.4%
21,100
+84.9%
0.05%
+42.1%
Q2 2016$273,000
+1606.2%
11,409
+1577.8%
0.04%
+1800.0%
Q1 2016$16,000
-71.4%
680
-51.4%
0.00%
-75.0%
Q3 2015$56,000
+166.7%
1,400
+366.7%
0.01%
+166.7%
Q2 2015$21,000
-89.4%
300
-95.2%
0.00%
-89.3%
Q3 2014$198,000
+32.9%
6,200
-13.9%
0.03%
+40.0%
Q2 2014$149,000
+132.8%
7,200
+118.2%
0.02%
+122.2%
Q1 2014$64,000
-12.3%
3,300
-3.2%
0.01%
-25.0%
Q3 2013$73,000
-89.8%
3,408
-88.7%
0.01%
-91.0%
Q1 2013$719,00030,1460.13%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders